Barely Significant
← all excerpts

Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advances.

Int J Surg · 2024 · PMC11175801 · PMID 38518083

Europe PMCDOI
1
hedged sentence
0.0790
closest p · 1.6× alpha
0.0790
boldest claim

The sentences

showed a trendP =0.079so close (0.05 < p ≤ 0.1)
The experimental group showed a trend toward a higher pCR rate ( P =0.079).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.